Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Jun;103(2):1411–1416. doi: 10.1111/j.1476-5381.1991.tb09803.x

Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres.

E Delpón 1, C Valenzuela 1, J Tamargo 1
PMCID: PMC1908390  PMID: 1909200

Abstract

1. The effects of flecainide alone, mexiletine alone and their combination at the Na+ channel level were studied in guinea-pig papillary muscles. The maximum upstroke velocity (Vmax) was used as an indirect index of the magnitude of the fast inward Na+ current (INa). 2. In muscles driven at 0.02 Hz, neither mexiletine (10(-5) M) nor flecainide (10(-6) M) nor the combination of both drugs modified the action potential characteristics. Mexiletine, but not flecainide, increased the effective refractory period/action potential duration ratio; this enhancement was greater when flecainide was also present. 3. Mexiletine or flecainide alone produced a frequency-dependent Vmax block. Although at 0.5 Hz the blockade induced by the combination of flecainide and mexiletine was similar to that produced by flecainide alone, in muscles driven at 1 and 2 Hz the combination increased the magnitude and the onset rate of the Vmax block. 4. The time constant of recovery of Vmax block was similar in the presence of flecainide or the combination mexiletine plus flecainide (tau re = 16.4 +/- 2.3 s and 16.7 +/- 2.7 s, respectively), but the combination decreased the magnitude of the slow component of reactivation induced by flecainide (93.8 +/- 1.5% versus 68.9 +/- 1.7%). Moreover, the combination of both drugs was more effective in inhibiting the Vmax of early test stimuli than either drug alone. 5. It is concluded that the combination of mexiletine and flecainide is synergistic at driving rates faster than 0.5 Hz without detracting from the characteristics of flecainide.

Full text

PDF
1411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Stewart J. R., Perry B. A., Van Hamersveld D. D., Johnson T. A., Conard G. J., Chang S. F., Kvam D. C., Pitt B. Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med. 1981 Aug 27;305(9):473–477. doi: 10.1056/NEJM198108273050901. [DOI] [PubMed] [Google Scholar]
  2. Anno T., Hondeghem L. M. Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ Res. 1990 Mar;66(3):789–803. doi: 10.1161/01.res.66.3.789. [DOI] [PubMed] [Google Scholar]
  3. Campbell R. W. Mexiletine. N Engl J Med. 1987 Jan 1;316(1):29–34. doi: 10.1056/NEJM198701013160106. [DOI] [PubMed] [Google Scholar]
  4. Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
  5. Campbell T. J. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):291–296. doi: 10.1097/00005344-198303000-00021. [DOI] [PubMed] [Google Scholar]
  6. Campbell T. J., Vaughan Williams E. M. Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res. 1983 May;17(5):251–258. doi: 10.1093/cvr/17.5.251. [DOI] [PubMed] [Google Scholar]
  7. Clarkson C. W., Hondeghem L. M. Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium. Circ Res. 1985 Apr;56(4):496–506. doi: 10.1161/01.res.56.4.496. [DOI] [PubMed] [Google Scholar]
  8. Clarkson C. W., Matsubara T., Hondeghem L. M. Slow inactivation of Vmax in guinea pig ventricular myocardium. Am J Physiol. 1984 Oct;247(4 Pt 2):H645–H654. doi: 10.1152/ajpheart.1984.247.4.H645. [DOI] [PubMed] [Google Scholar]
  9. Courtney K. R. Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle. Eur J Pharmacol. 1981 Aug 27;74(1):9–18. doi: 10.1016/0014-2999(81)90317-4. [DOI] [PubMed] [Google Scholar]
  10. Courtney K. R. Quantifying antiarrhythmic drug blocking during action potentials in guinea-pig papillary muscle. J Mol Cell Cardiol. 1983 Nov;15(11):749–757. doi: 10.1016/0022-2828(83)90334-6. [DOI] [PubMed] [Google Scholar]
  11. Courtney K. R. Structure-activity relations for frequency-dependent sodium channel block in nerve by local anesthetics. J Pharmacol Exp Ther. 1980 Apr;213(1):114–119. [PubMed] [Google Scholar]
  12. Delpón E., Valenzuela C., Tamargo J. Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle. Br J Pharmacol. 1989 Apr;96(4):970–976. doi: 10.1111/j.1476-5381.1989.tb11909.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Delpón E., Valenzuela C., Tamargo J. Tonic and frequency-dependent Vmax block induced by imipramine in guinea pig ventricular muscle fibers. J Cardiovasc Pharmacol. 1990 Mar;15(3):414–420. doi: 10.1097/00005344-199003000-00011. [DOI] [PubMed] [Google Scholar]
  14. Duff H. J., Roden D. M., Maffucci R. J., Vesper B. S., Conard G. J., Higgins S. B., Oates J. A., Smith R. F., Woosley R. L. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol. 1981 Dec;48(6):1133–1140. doi: 10.1016/0002-9149(81)90331-3. [DOI] [PubMed] [Google Scholar]
  15. Grant A. O., Starmer C. F., Strauss H. C. Antiarrhythmic drug action. Blockade of the inward sodium current. Circ Res. 1984 Oct;55(4):427–439. doi: 10.1161/01.res.55.4.427. [DOI] [PubMed] [Google Scholar]
  16. Hering S., Bodewei R., Wollenberger A. Sodium current in freshly isolated and in cultured single rat myocardial cells: frequency and voltage-dependent block by mexiletine. J Mol Cell Cardiol. 1983 Jul;15(7):431–444. doi: 10.1016/0022-2828(83)90263-8. [DOI] [PubMed] [Google Scholar]
  17. Hohnloser S., Weirich J., Antoni H. Effects of mexiletine on steady-state characteristics and recovery kinetics of V max and conduction velocity in guinea pig myocardium. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):232–239. doi: 10.1097/00005344-198203000-00011. [DOI] [PubMed] [Google Scholar]
  18. Holmes B., Heel R. C. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985 Jan;29(1):1–33. doi: 10.2165/00003495-198529010-00001. [DOI] [PubMed] [Google Scholar]
  19. Hondeghem L. M. Antiarrhythmic agents: modulated receptor applications. Circulation. 1987 Mar;75(3):514–520. doi: 10.1161/01.cir.75.3.514. [DOI] [PubMed] [Google Scholar]
  20. Hondeghem L. M., Katzung B. G. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol. 1984;24:387–423. doi: 10.1146/annurev.pa.24.040184.002131. [DOI] [PubMed] [Google Scholar]
  21. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  22. Kohlhardt M., Seifert C. Properties of Vmax block of INa-mediated action potentials during combined application of antiarrhythmic drugs in cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):235–244. doi: 10.1007/BF00572439. [DOI] [PubMed] [Google Scholar]
  23. Morganroth J. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias. Am J Cardiol. 1987 Dec 1;60(16):1276–1281. doi: 10.1016/0002-9149(87)90608-4. [DOI] [PubMed] [Google Scholar]
  24. Neuss H., Buss J., Schlepper M., Berthold R., Mitrović V., Krämer A., Musial W. J. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome. Eur Heart J. 1983 May;4(5):347–353. doi: 10.1093/oxfordjournals.eurheartj.a061472. [DOI] [PubMed] [Google Scholar]
  25. Saikawa T., Carmeliet E. Slow recovery of the maximal rate of rise (Vmax) of the action potential in sheep cardiac Purkinje fibers. Pflugers Arch. 1982 Jul;394(1):90–93. doi: 10.1007/BF01108313. [DOI] [PubMed] [Google Scholar]
  26. Sheets M. F., Hanck D. A., Fozzard H. A. Nonlinear relation between Vmax and INa in canine cardiac Purkinje cells. Circ Res. 1988 Aug;63(2):386–398. doi: 10.1161/01.res.63.2.386. [DOI] [PubMed] [Google Scholar]
  27. Somberg J. C., Tepper D. Flecainide: a new antiarrhythmic agent. Am Heart J. 1986 Oct;112(4):808–813. doi: 10.1016/0002-8703(86)90478-3. [DOI] [PubMed] [Google Scholar]
  28. Sánchez-Chapula J. Electrophysiological interactions between quinidine-lidocaine and quinidine-phenytoin in guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol. 1985 Dec;331(4):369–375. doi: 10.1007/BF00500822. [DOI] [PubMed] [Google Scholar]
  29. Tamargo J., Rodriguez S., Garcia de Jaloń P. Electrophysiological effects of desipramine on guinea pig papillary muscles. Eur J Pharmacol. 1979 Apr 15;55(2):171–179. doi: 10.1016/0014-2999(79)90389-3. [DOI] [PubMed] [Google Scholar]
  30. Valenzuela C., Delpón E., Tamargo J. Electrophysiologic interactions between mexiletine and propafenone in guinea pig papillary muscles. J Cardiovasc Pharmacol. 1989 Sep;14(3):351–357. doi: 10.1097/00005344-198909000-00001. [DOI] [PubMed] [Google Scholar]
  31. Valenzuela C., Delpón E., Tamargo J. Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles. J Cardiovasc Pharmacol. 1988 Oct;12(4):423–431. doi: 10.1097/00005344-198810000-00007. [DOI] [PubMed] [Google Scholar]
  32. Valenzuela C., Sanchez-Chapula J. Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle. J Cardiovasc Pharmacol. 1989 Nov;14(5):783–789. doi: 10.1097/00005344-198911000-00016. [DOI] [PubMed] [Google Scholar]
  33. Varro A., Elharrar V., Surawicz B. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers. J Cardiovasc Pharmacol. 1985 May-Jun;7(3):482–492. doi: 10.1097/00005344-198505000-00011. [DOI] [PubMed] [Google Scholar]
  34. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  35. Yatani A., Akaike N. Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. J Mol Cell Cardiol. 1985 May;17(5):467–476. doi: 10.1016/s0022-2828(85)80051-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES